Cover Image
市場調查報告書

側流化驗的全球市場預測 2020年:妊娠檢驗、傳染病檢查、膽固醇檢驗、心臟標記、動物用診斷、藥物研發

Lateral Flow Assay Market by Product (Reader, Kits) Application (Clinical Testing (Pregnancy, Infectious Disease, Cholestrol, Cardiac Marker), Veterinary, Drug Development) Technique (Sandwich, Competitive, Multiplex) End User - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 354421
出版日期 內容資訊 英文 212 Pages
訂單完成後即時交付
價格
Back to Top
側流化驗的全球市場預測 2020年:妊娠檢驗、傳染病檢查、膽固醇檢驗、心臟標記、動物用診斷、藥物研發 Lateral Flow Assay Market by Product (Reader, Kits) Application (Clinical Testing (Pregnancy, Infectious Disease, Cholestrol, Cardiac Marker), Veterinary, Drug Development) Technique (Sandwich, Competitive, Multiplex) End User - Global Forecast to 2020
出版日期: 2016年03月11日 內容資訊: 英文 212 Pages
簡介

全球側流化驗市場規模,預計從2015到2020年以8.3%的年複合成長率發展,到2020年達到67億8,000萬美元。該市場的成長主要由於老年人口的增加,感染疾病的高發病率,家庭側流化驗實驗的利用擴大,分散式或照護現場診斷檢驗的關注高漲,及臨床診斷的側流化驗技術用途的增加而受促進。

本報告提供全球側流化驗市場相關分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 側流化驗市場概要
  • 亞太地區的側流化驗市場:各技術
  • 側流化驗市場:地區概要
  • 側流化驗市場:地區混合
  • 側流化驗市場:新興國家 vs. 已開發國家/地區

第5章 市場概要

  • 簡介
  • 市場區隔
    • 各產品
    • 各技術
    • 各應用領域
    • 各終端用戶
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 課題

第6章 產業考察

  • 簡介
  • 法規分析
  • 價值鏈分析
  • 供應鏈分析

第7章 全球側流化驗市場:各產品

  • 簡介
  • 套件 & 試劑
  • 側流領導者
    • 數位/行動領導者
    • 桌面式領導者

第8章 全球側流化驗市場:各技術

  • 簡介
  • 三明治化驗 (非競爭法)
  • 競爭化驗 (競爭法)
  • 多重檢測化驗

第9章 側流化驗市場:各應用領域

  • 簡介
  • 臨床/就地檢驗
    • 傳染病檢查
    • 心臟標記檢驗
    • 妊娠、妊娠檢驗
    • 膽固醇/脂質檢驗
    • 藥物濫用檢測
    • 其他檢驗
  • 動物用診斷
  • 藥物研發

第10章 全球側流化驗市場:各終端用戶

  • 簡介
  • 醫院、診所
  • 居家醫療
  • 診斷實驗室
  • 醫藥品、生物科技企業

第11章 側流化驗市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他的亞太地區
  • 其他 (RoW)
    • 南美
    • 中東、非洲

第12章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢

第13章 企業簡介

  • 簡介
  • ALERE INC.
    • 產業概要
    • 提供產品
    • 近幾年的發展趨勢
    • MNM的見解
  • F. HOFFMANN-LA ROCHE AG
  • DANAHER CORPORATION
  • ABBOTT LABORATORIES, INC.
  • SIEMENS AG
  • JOHNSON & JOHNSON
  • BECTON, DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • QIAGEN N.V.

第14章 附錄

圖表清單

目錄
Product Code: MD 4158

The global lateral flow assay market is expected to grow at a strong CAGR of 8.3% during the forecast period of 2015 to 2020 and is estimated to reach USD 6.78 billion by 2020. The growth in this market is majorly driven by the rising geriatric population, high prevalence of infectious diseases, rising usage of home-based lateral flow assay tests, improved focus on decentralized or point-of-care diagnostic testing, and increasing application of lateral flow assay techniques in clinical diagnostics. However, difficulty in obtaining regulatory approvals due to the constantly changing standards, variance in test results, and insufficient reimbursements for lateral flow assay procedures are posing several challenges to the overall growth of the market.

In this report, the lateral flow assay market is segmented based on products, techniques, applications, end users, and region. Based on products, the market is segmented into kits & reagents and lateral flow readers. The lateral flow readers market is subsegmented into digital/mobile readers and benchtop readers. Based on technique, the market is segmented into sandwich assay, competitive assay, and multiplex detection assay. During the forecast period, the sandwich assay segment will continue to dominate the lateral flow assay market. This is primarily attributed to the successful application of this technique in various areas, especially clinical testing.

By 2020, North America is expected to account for the largest share of the global lateral flow assay market, followed by Europe, Asia-Pacific, and RoW. However, markets in developed geographies like North America and Europe are expected to grow at lower CAGRs as compared to the Asia-Pacific. This is because the Asia-Pacific region is characterized by favorable factors for market growth, such as rising healthcare awareness, presence of less stringent regulations, improving healthcare infrastructure, and increasing demand for quality healthcare at low costs.

The major players in the lateral flow assay market include Alere, Inc. (U.S.), F. Hoffmann-La Roche AG (Germany), Danaher Corporation (U.S.), Abbott Laboratories, Inc. (U.S.), Becton, Dickinson and Company (BD) (U.S.), Siemens Healthcare (Germany), and Thermo Fisher Scientific, Inc. (U.S.).

Alere, Inc. (U.S.), F. Hoffmann-La Roche AG (Germany), Danaher Corporation (U.S.), and Abbott Laboratories, Inc. (U.S.) were the leading players in the global lateral flow assay market in 2014. Alere, Inc. offers a diversified portfolio of lateral flow assay systems, majorly in rapid diagnostics, including a wide range of clinical diagnostic tools used in toxicology and for the diagnosis of cardiometabolic and infectious diseases. The company's leading position in the lateral flow assay market can also be attributed to its strong focus on innovations. Other leading players like F. Hoffmann-La Roche AG and Danaher Corporation have a strong geographic presence with business operations in several geographies, including Europe, North America, Latin America, Asia, Middle East, and Africa.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market which in turn would help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping a greater market share.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the lateral flow assay market. The report analyzes the lateral flow assay market by technique, product, application, and end user across all regions.
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and new product launches in the lateral flow assay market.
  • Market Development: Comprehensive information of the lucrative emerging markets by technique, product, application, end user, and geography.
  • Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the global lateral flow assay market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of the leading players in the global lateral flow assay market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. SECONDARY SOURCES
    • 2.5.1. KEY DATA FROM SECONDARY SOURCES
  • 2.6. PRIMARY SOURCES
    • 2.6.1. KEY DATA FROM PRIMARY SOURCES
    • 2.6.2. KEY INDUSTRY INSIGHTS
  • 2.7. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. LATERAL FLOW ASSAY MARKET OVERVIEW
  • 4.2. ASIA-PACIFIC LATERAL FLOW ASSAY MARKET, BY TECHNOLOGY
  • 4.3. LATERAL FLOW ASSAY MARKET: GEOGRAPHIC SNAPSHOT
  • 4.4. LATERAL FLOW ASSAY MARKET: GEOGRAPHIC MIX
  • 4.5. LATERAL FLOW ASSAY MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY PRODUCT
    • 5.2.2. BY TECHNIQUE
    • 5.2.3. BY APPLICATION
    • 5.2.4. BY END USER
  • 5.3. KEY MARKET DYNAMICS
    • 5.3.1. MARKET DRIVERS
      • 5.3.1.1. High prevalence of infectious diseases
      • 5.3.1.2. Rapidly increasing geriatric population
      • 5.3.1.3. Increasing usage of home-based lateral flow assay devices
      • 5.3.1.4. Growing demand for point-of-care testing
      • 5.3.1.5. Rising healthcare costs
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Reluctance towards changing existing diagnostics practices
      • 5.3.2.2. Implementation of excise duty on medical devices by the U.S. government
      • 5.3.2.3. Stringent and time-consuming regulatory policies
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Growing application of lateral flow assay tests in clinical diagnostics
      • 5.3.3.2. Miniaturization and technological advancements
      • 5.3.3.3. Rising focus on microfluidics devices
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Limited reimbursement for lateral flow assay products

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. REGULATORY ANALYSIS
  • 6.3. VALUE CHAIN ANALYSIS
  • 6.4. SUPPLY CHAIN ANALYSIS

7. GLOBAL LATERAL FLOW ASSAY MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. KITS & REAGENTS
  • 7.3. LATERAL FLOW READERS
    • 7.3.1. DIGITAL/MOBILE READERS
    • 7.3.2. BENCHTOP READERS

8. GLOBAL LATERAL FLOW ASSAY MARKET, BY TECHNIQUE

  • 8.1. INTRODUCTION
  • 8.2. SANDWICH ASSAYS
  • 8.3. COMPETITIVE ASSAYS
  • 8.4. MULTIPLEX DETECTION ASSAYS

9. LATERAL FLOW ASSAY MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. CLINICAL/POINT-OF-CARE TESTING
    • 9.2.1. INFECTIOUS DISEASE TESTING
    • 9.2.2. CARDIAC MARKER TESTING
    • 9.2.3. PREGNANCY AND FERTILITY TESTING
      • 9.2.3.1. Pregnancy Testing
      • 9.2.3.2. Fertility Testing Market
    • 9.2.4. CHOLESTEROL/LIPID TESTING
    • 9.2.5. DRUGS-OF-ABUSE TESTING
    • 9.2.6. OTHER TESTS
  • 9.3. VETERINARY DIAGNOSTICS
  • 9.4. DRUG DEVELOPMENT

10. GLOBAL LATERAL FLOW ASSAY MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. HOSPITALS AND CLINICS
  • 10.3. HOME CARE
  • 10.4. DIAGNOSTIC LABORATORIES
  • 10.5. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

11. LATERAL FLOW ASSAY MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. FRANCE
    • 11.3.3. U.K.
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE
  • 11.4. ASIA-PACIFIC
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA-PACIFIC
  • 11.5. REST OF THE WORLD (ROW)
    • 11.5.1. LATIN AMERICA
    • 11.5.2. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE ANALYSIS
  • 12.3. COMPETITIVE SITUATION AND TRENDS
    • 12.3.1. NEW PRODUCT LAUNCHES
    • 12.3.2. PARTNERSHIPS AND COLLABORATIONS
    • 12.3.3. MERGERS AND ACQUISITIONS
    • 12.3.4. EXPANSION

13. COMPANY PROFILES

  • 13.1. INTRODUCTION
  • 13.2. ALERE INC.
    • 13.2.1. BUSINESS OVERVIEW
    • 13.2.2. PRODUCTS OFFERED
    • 13.2.3. RECENT DEVELOPMENTS
    • 13.2.4. MNM VIEW
  • 13.3. F. HOFFMANN-LA ROCHE AG
    • 13.3.1. INTRODUCTION
    • 13.3.2. PRODUCTS OFFERED
    • 13.3.3. RECENT DEVELOPMENTS
    • 13.3.4. MNM VIEW
  • 13.4. DANAHER CORPORATION
    • 13.4.1. BUSINESS OVERVIEW
    • 13.4.2. PRODUCTS OFFERED
    • 13.4.3. RECENT DEVELOPMENTS
    • 13.4.4. MNM VIEW
  • 13.5. ABBOTT LABORATORIES, INC.
    • 13.5.1. BUSINESS OVERVIEW
    • 13.5.2. PRODUCTS OFFERED
    • 13.5.3. RECENT DEVELOPMENTS
    • 13.5.4. MNM VIEW
  • 13.6. SIEMENS AG
    • 13.6.1. BUSINESS OVERVIEW
    • 13.6.2. PRODUCTS OFFERED
    • 13.6.3. RECENT DEVELOPMENTS
  • 13.7. JOHNSON & JOHNSON
    • 13.7.1. BUSINESS OVERVIEW
    • 13.7.2. PRODUCTS OFFERED
    • 13.7.3. RECENT DEVELOPMENTS
    • 13.7.4. MNM VIEW
  • 13.8. BECTON, DICKINSON AND COMPANY
    • 13.8.1. BUSINESS OVERVIEW
    • 13.8.2. PRODUCTS OFFERED
    • 13.8.3. RECENT DEVELOPMENTS
  • 13.9. BIOMERIEUX SA
    • 13.9.1. BUSINESS OVERVIEW
    • 13.9.2. PRODUCTS OFFERED
    • 13.9.3. RECENT DEVELOPMENTS
  • 13.10. BIO-RAD LABORATORIES, INC.
    • 13.10.1. BUSINESS OVERVIEW
    • 13.10.2. PRODUCTS OFFERED
    • 13.10.3. RECENT DEVELOPMENTS
  • 13.11. THERMO FISHER SCIENTIFIC, INC.
    • 13.11.1. BUSINESS OVERVIEW
    • 13.11.2. PRODUCTS OFFERED
    • 13.11.3. RECENT DEVELOPMENTS
  • 13.12. QIAGEN N.V.
    • 13.12.1. BUSINESS OVERVIEW
    • 13.12.2. PRODUCTS OFFERED
    • 13.12.3. RECENT DEVELOPMENTS

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS
  • 14.4. AVAILABLE CUSTOMIZATIONS
  • 14.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: PREVALENCE OF INFECTIOUS DISEASES WORLDWIDE (2014)
  • TABLE 2: RISING DEMAND FOR POINT-OF-CARE TESTING TO BOOST MARKET GROWTH
  • TABLE 3: RELUCTANCE TOWARDS CHANGING EXISTING DIAGNOSTICS PRACTICES TO HINDER MARKET GROWTH
  • TABLE 4: GROWING APPLICATION OF LATERAL FLOW ASSAY TESTS IN CLINICAL DIAGNOSTICS TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES FOR MARKET PLAYERS
  • TABLE 5: LIMITED REIMBURSEMENT FOR LATERAL FLOW ASSAY PRODUCTS IS A MAJOR MARKET CHALLENGE
  • TABLE 6: REGULATORY STANDARD/APPROVAL REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION
  • TABLE 7: GLOBAL LATERAL FLOW ASSAY MARKET, BY PRODUCT (2013-2020)
  • TABLE 8: POPULAR LABELING METHODS
  • TABLE 9: KITS & REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 10: LATERAL FLOW READERS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 11: LATERAL FLOW READERS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 12: DIGITAL/MOBILE READERS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 13: BENCHTOP READERS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 14: GLOBAL LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 15: LATERAL FLOW SANDWICH ASSAYS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 16: LATERAL FLOW COMPETITIVE ASSAYS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 17: LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 18: GLOBAL LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 19: OVERVIEW OF LATERAL FLOW ASSAYS: DETECTION OF INFECTIOUS AGENTS, METABOLIC DISORDERS, AND TOXIC COMPOUNDS
  • TABLE 20: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 21: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 22: LATERAL FLOW ASSAY MARKET SIZE FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 23: LATERAL FLOW ASSAY MARKET SIZE FOR CARDIAC MARKER TESTING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 24: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 25: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 26: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY TESTING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 27: LATERAL FLOW ASSAY MARKET SIZE FOR FERTILITY TESTING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 28: LATERAL FLOW ASSAY MARKET SIZE FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 29: USUAL CUT-OFF CONCENTRATIONS FOR VARIOUS DRUGS IN POINT-OF-CARE TESTING DEVICES FOR URINE SPECIMENS
  • TABLE 30: LATERAL FLOW ASSAY MARKET SIZE FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 31: LATERAL FLOW ASSAY MARKET SIZE FOR OTHER TESTS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 32: LATERAL FLOW ASSAY MARKET SIZE FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 33: LATERAL FLOW ASSAY MARKET SIZE FOR DRUG DEVELOPMENT, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 34: GLOBAL LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 35: LATERAL FLOW ASSAY MARKET SIZE FOR HOSPITALS AND CLINICS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 36: LATERAL FLOW ASSAY MARKET SIZE FOR HOME CARE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 37: LATERAL FLOW ASSAY MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 38: LATERAL FLOW ASSAY MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 39: NORTH AMERICA: LATERAL FLOW ASSAY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 40: NORTH AMERICA: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 41: NORTH AMERICA: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 42: NORTH AMERICA: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 43: NORTH AMERICA: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 44: NORTH AMERICA: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 45: NORTH AMERICA: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 46: NORTH AMERICA: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 47: U.S.: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 48: U.S.: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 49: U.S.: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 50: U.S.: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 51: U.S.: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 52: U.S.: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 53: U.S.: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 54: CANADA: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 55: CANADA: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 56: CANADA: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 57: CANADA: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 58: CANADA: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: CANADA: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 60: CANADA: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 61: EUROPE: LATERAL FLOW ASSAY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 62: EUROPE: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 63: EUROPE: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: EUROPE: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 65: EUROPE: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 66: EUROPE: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 67: EUROPE: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 68: EUROPE: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 69: GERMANY: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 70: GERMANY: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 71: GERMANY: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 72: GERMANY: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 73: GERMANY: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 74: GERMANY: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 75: GERMANY: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 76: FRANCE: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 77: FRANCE: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 78: FRANCE: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 79: FRANCE: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 80: FRANCE: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 81: FRANCE: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 82: FRANCE: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 83: U.K.: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 84: U.K.: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 85: U.K.: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 86: U.K.: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 87: U.K.: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 88: U.K.: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 89: U.K.: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 90: ITALY: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 91: ITALY: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 92: ITALY: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 93: ITALY: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 94: ITALY: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 95: ITALY: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 96: ITALY: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 97: SPAIN: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 98: SPAIN: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 99: SPAIN: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 100: SPAIN: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 101: SPAIN: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 102: SPAIN: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 103: SPAIN: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 104: ROE: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 105: ROE: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 106: ROE: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 107: ROE: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 108: ROE: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 109: ROE: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 110: ROE: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 111: APAC: PERCENTAGE OF TOTAL DEATHS CAUSED BY NON-COMMUNICABLE DISEASES, BY COUNTRY, 2013
  • TABLE 112: APAC: LATERAL FLOW ASSAY MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 113: APAC: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 114: APAC: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 115: APAC: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 116: APAC: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 117: APAC: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 118: APAC: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 119: APAC: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 120: JAPAN: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 121: JAPAN: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 122: JAPAN: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 123: JAPAN: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 124: APAC: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 125: JAPAN: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 126: JAPAN: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 127: CHINA: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 128: CHINA: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 129: CHINA: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 130: CHINA: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 131: CHINA: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 132: CHINA: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 133: CHINA: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 134: INDIA: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 135: INDIA: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 136: INDIA: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 137: INDIA: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 138: INDIA: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 139: INDIA: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 140: INDIA: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 141: ROAPAC: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 142: ROAPAC: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 143: ROAPAC: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 144: ROAPAC: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 145: ROAPAC: LATERAL FLOW ASSAY MARKET SIZE FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 146: ROAPAC: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 147: ROAPAC: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 148: ROW: LATERAL FLOW ASSAY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 149: ROW: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 150: ROW: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 151: ROW: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 152: ROW: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 153: ROW: LATERAL FLOW ASSAY MARKET FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 154: ROW: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 155: ROW: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 156: LATIN AMERICA: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 157: LATIN AMERICA: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 158: LATIN AMERICA: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 159: LATIN AMERICA: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 160: LATIN AMERICA: LATERAL FLOW ASSAY MARKET FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 161: LATIN AMERICA: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 162: LATIN AMERICA: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 163: MIDDLE EAST AND AFRICA: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 164: MIDDLE EAST AND AFRICA: LATERAL FLOW READERS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 165: MIDDLE EAST AND AFRICA: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2013-2020 (USD MILLION)
  • TABLE 166: MIDDLE EAST AND AFRICA: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 167: MIDDLE EAST AND AFRICA: LATERAL FLOW ASSAY MARKET FOR CLINICAL/POINT-OF-CARE TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 168: MIDDLE EAST AND AFRICA: LATERAL FLOW ASSAY MARKET SIZE FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 169: MIDDLE EAST AND AFRICA: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 170: GROWTH STRATEGY MATRIX, 2012-2016
  • TABLE 171: RECENT DEVELOPMENTS, 2015
  • TABLE 172: RECENT DEVELOPMENTS, 2015-2016
  • TABLE 173: RECENT DEVELOPMENTS, 2014-2016
  • TABLE 174: RECENT DEVELOPMENTS, 2012-2014

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BOTTOM-UP APPROACH
  • FIGURE 3: TOP-DOWN APPROACH
  • FIGURE 4: DATA TRIANGULATION METHODOLOGY
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: LATERAL FLOW ASSAY MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION)
  • FIGURE 7: LATERAL FLOW ASSAY MARKET SIZE, BY TECHNIQUE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 8: LATERAL FLOW ASSAY MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 9: LATERAL FLOW ASSAY MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY MARKET, 2014
  • FIGURE 11: RISING DEMAND FOR POINT-OF-CARE TESTING TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12: THE SANDWICH ASSAYS SEGMENT COMMANDED THE LARGEST SHARE OF THE ASIA-PACIFIC LATERAL FLOW ASSAY MARKET IN 2014
  • FIGURE 13: THE U.S. DOMINATED THE GLOBAL LATERAL FLOW ASSAY MARKET IN 2014
  • FIGURE 14: NORTH AMERICA TO DOMINATE THE LATERAL FLOW ASSAY MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: CHINA TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: LATERAL FLOW ASSAY MARKET, BY PRODUCT
  • FIGURE 17: LATERAL FLOW ASSAY MARKET, BY TECHNIQUE
  • FIGURE 18: LATERAL FLOW ASSAY MARKET, BY APPLICATION
  • FIGURE 19: LATERAL FLOW ASSAY MARKET, BY END USER
  • FIGURE 20: LATERAL FLOW ASSAY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 21: PREVALENCE OF HIV INFECTIONS ACROSS GLOBE, 2013
  • FIGURE 22: GLOBAL ELDERLY POPULATION, BY REGION
  • FIGURE 23: LATERAL FLOW ASSAY MARKET: VALUE CHAIN ANALYSIS (2015)
  • FIGURE 24: LATERAL FLOW ASSAY MARKET: SUPPLY CHAIN ANALYSIS (2015)
  • FIGURE 25: KITS & REAGENTS TO HOLD THE LARGEST SHARE OF THE GLOBAL LATERAL FLOW ASSAY MARKET IN 2020
  • FIGURE 26: DIGITAL/MOBILE READERS WILL CONTINUE TO DOMINATE THE LATERAL FLOW READERS MARKET IN 2020
  • FIGURE 27: THE SANDWICH ASSAYS TECHNIQUE DOMINATES THE GLOBAL LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, IN 2015
  • FIGURE 28: CLINICAL/POINT-OF-CARE TESTING SEGMENT TO DOMINATE THE GLOBAL LATERAL FLOW ASSAY MARKET FROM 2015 TO 2020
  • FIGURE 29: HOSPITALS AND CLINICS WILL CONTINUE TO DOMINATE THE LATERAL FLOW ASSAY MARKET IN 2020
  • FIGURE 30: GEOGRAPHIC SNAPSHOT (2014): LATERAL FLOW ASSAY MARKET IN CHINA EXPECTED TO WITNESS HIGHEST GROWTH
  • FIGURE 31: NORTH AMERICA: LATERAL FLOW ASSAY MARKET SNAPSHOT
  • FIGURE 32: EUROPE: LATERAL FLOW ASSAY MARKET SNAPSHOT
  • FIGURE 33: APAC LATERAL FLOW ASSAY MARKET SNAPSHOT
  • FIGURE 34: NEW PRODUCT LAUNCHES-THE MOST WIDELY ADOPTED GROWTH STRATEGY PURSUED BY LEADING PLAYERS BETWEEN 2012 AND 2016
  • FIGURE 35: LATERAL FLOW ASSAY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 36: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY
  • FIGURE 37: GEOGRAPHIC REVENUE MIX OF THE TOP FIVE PLAYERS
  • FIGURE 38: COMPANY SNAPSHOT: ALERE INC.
  • FIGURE 39: COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE AG
  • FIGURE 40: COMPANY SNAPSHOT: DANAHER CORPORATION
  • FIGURE 41: COMPANY SNAPSHOT: ABBOTT LABORATORIES, INC.
  • FIGURE 42: COMPANY SNAPSHOT: SIEMENS AG
  • FIGURE 43: COMPANY SNAPSHOT: JOHNSON & JOHNSON
  • FIGURE 44: COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY
  • FIGURE 45: COMPANY SNAPSHOT: BIOMERIEUX
  • FIGURE 46: COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC.
  • FIGURE 47: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC.
  • FIGURE 48: COMPANY SNAPSHOT: QIAGEN N.V.
Back to Top